1. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. (January 2022) Authors: Vermeire, Severine; Lakatos, Peter L; Ritter, Timothy; Hanauer, Stephen; Bressler, Brian; Khanna, Reena; Isaacs, Kim; Shah, Saumin; Kadva, Alysha; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Eden, Christopher; Zhang, Wenhui; Feagan, Brian G; Abraham, Philip; Acir Crip... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 1(2022) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0056 MAINTENANCE OF CLINICAL RESPONSE IN INDIVIDUAL CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH SUBCUTANEOUS ABATACEPT. (June 2019) Authors: Ruperto, Nicolino; Brunner, Hermine; Tzaribachev, Nikolay; Louw, Ingrid; Calvo, Inmaculada; Zapata, Francisco; Horneff, Gerd; Foeldvari, Ivan; Kingsbury, Daniel; Joos, Rik; Gastanaga, Maria; Wouters, Carine; Breedt, Johannes; Lutz, Thomas; Miraval, Tatiana; Rubio, Nadina; Elbez, Yedid; Nys, Marle... Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗